Brokerages Set Savaria Co. (TSE:SIS) Price Target at C$26.67

Savaria Co. (TSE:SIS) has been assigned a consensus rating of “Buy” from the seven analysts that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is C$30.93.

Several equities research analysts have issued reports on SIS shares. National Bank Financial lifted their target price on shares of Savaria from C$30.00 to C$30.50 and gave the stock an “outperform” rating in a research note on Friday. Scotiabank increased their target price on shares of Savaria from C$29.00 to C$30.00 and gave the company an “outperform” rating in a research report on Friday. ATB Cormark Capital Markets raised their price target on shares of Savaria from C$30.00 to C$32.00 and gave the stock an “outperform” rating in a research note on Friday. TD Securities boosted their price target on shares of Savaria from C$27.00 to C$31.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Stifel Nicolaus upped their price objective on shares of Savaria from C$28.00 to C$29.00 and gave the company a “buy” rating in a research note on Friday.

Savaria News Summary

Here are the key news stories impacting Savaria this week:

• Positive Sentiment: Multiple brokerages raised price targets and upgraded ratings this morning (ATB Cormark to C$32, Raymond James to C$32, National Bank to C$30.50, Scotiabank to C$30, Desjardins to C$32, Stifel and TD also higher). These raises signal stronger analyst confidence and imply double‑digit upside from current levels. Analyst Rating Roundup
• Positive Sentiment: Savaria reported record 2025 results and stronger margins, with Q4 revenue of C$241.8M and EPS C$0.37 — results the company says position it for a new growth phase around its Savaria One strategy. This fundamental momentum underpins the analyst upgrades. Record 2025 Results
• Positive Sentiment: Coverage pieces note Savaria “entering a new growth phase” after completion of Savaria One and record Q4, reinforcing the narrative for higher future growth and margin improvement. Growth Phase Article
• Neutral Sentiment: The shares briefly hit a 12‑month high following the analyst activity and results, attracting attention from retail and institutional traders. 12‑Month High Coverage
• Neutral Sentiment: Management’s earnings release and conference call are available for review (detailed Q4 release and call transcript), useful for investors who want to assess guidance and cadence of margin improvement. Press Release / Transcript
• Negative Sentiment: Despite the positive newsflow, the stock is lower — likely reflecting short‑term profit‑taking after a run to a 52‑week high, elevated trading volume, and valuation concerns (current reported P/E ~29 and very high PEG). Those factors can pressure the share price even amid upgrades. Market Data / Valuation

Savaria Stock Performance

TSE SIS opened at C$25.52 on Monday. The company has a debt-to-equity ratio of 8.27, a current ratio of 1.61 and a quick ratio of 0.91. The stock’s 50 day simple moving average is C$24.64 and its 200-day simple moving average is C$22.52. The company has a market cap of C$1.83 billion, a PE ratio of 29.33, a price-to-earnings-growth ratio of 42.72 and a beta of 1.14. Savaria has a 1-year low of C$14.97 and a 1-year high of C$26.42.

Savaria (TSE:SIS) last issued its quarterly earnings results on Wednesday, March 4th. The company reported C$0.37 EPS for the quarter. Savaria had a return on equity of 11.10% and a net margin of 7.53%.The firm had revenue of C$241.78 million during the quarter. As a group, equities research analysts anticipate that Savaria will post 1.2048518 EPS for the current fiscal year.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.